Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
20/04/2022 | 18:39 | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:ZENO | Zenosense Inc NV (CE) |
16/03/2022 | 15:50 | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:ZENO | Zenosense Inc NV (CE) |
16/03/2022 | 11:05 | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:ZENO | Zenosense Inc NV (CE) |
01/03/2022 | 17:41 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | USOTC:ZENO | Zenosense Inc NV (CE) |
01/04/2019 | 21:00 | Edgar (US Regulatory) | Notification That Annual Report Will Be Submitted Late (nt 10-k) | USOTC:ZENO | Zenosense Inc NV (CE) |
02/10/2018 | 13:42 | InvestorsHub NewsWire | Zenosense, Inc.: MIDS Medical Expands Technical Team | USOTC:ZENO | Zenosense Inc NV (CE) |
05/09/2018 | 14:00 | InvestorsHub NewsWire | Zenosense, Inc.: MIDS Medical JV to Receive Funding of Up to $1.2 Million | USOTC:ZENO | Zenosense Inc NV (CE) |
14/08/2018 | 17:05 | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late (nt 10-q) | USOTC:ZENO | Zenosense Inc NV (CE) |
26/06/2018 | 14:45 | InvestorWire | Diagnostics Play Critical Role in Medical Sector | USOTC:ZENO | Zenosense Inc NV (CE) |
19/06/2018 | 13:52 | InvestorsHub NewsWire | Zenosense, Inc.: Breakthrough Quantitative MIDS Testing Results | USOTC:ZENO | Zenosense Inc NV (CE) |
16/11/2017 | 13:38 | InvestorsHub NewsWire | Zenosense, Inc.: MIDS Hybrid Strip - Successful Initial Test Results | USOTC:ZENO | Zenosense Inc NV (CE) |
05/07/2017 | 13:54 | InvestorsHub NewsWire | Zenosense, Inc. - MIDS Hybrid Strip Detection Testing to Commence | USOTC:ZENO | Zenosense Inc NV (CE) |
15/06/2017 | 13:47 | InvestorsHub NewsWire | Zenosense, Inc.: Issuance of U.S. MIDS Patent | USOTC:ZENO | Zenosense Inc NV (CE) |
19/05/2017 | 21:10 | Edgar (US Regulatory) | Amended Quarterly Report (10-q/a) | USOTC:ZENO | Zenosense Inc NV (CE) |
20/04/2017 | 15:00 | InvestorsHub NewsWire | What Cannabis Stocks Investors Should Know and Coverage of a Mobile Tech Sub Penny Stock | USOTC:ZENO | Zenosense Inc NV (CE) |
28/03/2017 | 15:15 | InvestorsHub NewsWire | Zenosense, Inc.: MIDS Medical Engages Future Diagnostics for Assay Consulting Services | USOTC:ZENO | Zenosense Inc NV (CE) |
10/03/2017 | 13:36 | InvestorsHub NewsWire | Zenosense, Inc.: MIDS Quantitative Testing Results | USOTC:ZENO | Zenosense Inc NV (CE) |
06/02/2017 | 21:10 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | USOTC:ZENO | Zenosense Inc NV (CE) |
23/01/2017 | 14:47 | InvestorsHub NewsWire | Zenosense, Inc.: New Patent Application for Additional MIDS Detection Method | USOTC:ZENO | Zenosense Inc NV (CE) |
17/11/2016 | 16:00 | InvestorsHub NewsWire | Zenosense, Inc. MIDS Proof of Market Report | USOTC:ZENO | Zenosense Inc NV (CE) |
29/06/2016 | 21:44 | Edgar (US Regulatory) | Information Statement - All Other (definitive) (def 14c) | USOTC:ZENO | Zenosense Inc NV (CE) |
17/06/2016 | 22:45 | Edgar (US Regulatory) | Proxy Statement - Other Information (preliminary) (pre 14c) | USOTC:ZENO | Zenosense Inc NV (CE) |
16/06/2016 | 23:11 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | USOTC:ZENO | Zenosense Inc NV (CE) |
16/06/2016 | 20:51 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | USOTC:ZENO | Zenosense Inc NV (CE) |
17/12/2014 | 14:50 | InvestorsHub NewsWire | Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial | USOTC:ZENO | Zenosense Inc NV (CE) |
27/10/2014 | 14:00 | eTeligis | Zenosense, Inc.; MRSA/SA Prototype Achieves over 95% Sensibility in Cultured Headspace | USOTC:ZENO | Zenosense Inc NV (CE) |
27/05/2014 | 14:30 | Marketwired | Zenosense, Inc. Highlights Recent Media Coverage of MRSA | USOTC:ZENO | Zenosense Inc NV (CE) |
21/05/2014 | 14:30 | Marketwired | Zenosense, Inc. Provides Development Update | USOTC:ZENO | Zenosense Inc NV (CE) |
08/05/2014 | 14:30 | Marketwired | Zenosense, Inc. Extends License to Include Cancer Applications | USOTC:ZENO | Zenosense Inc NV (CE) |
10/04/2014 | 15:27 | Marketwired | Zenosense, Inc. Enters Into $475,000 Securities Purchase Agreement | USOTC:ZENO | Zenosense Inc NV (CE) |